Business
Chimeric receives $2.5 M advance on FY25 R&D tax incentive
Chimeric receives $2.5 M advance on FY25 R&D tax incentive
About this update from Chimeric Therapeutics Limited
Chimeric Therapeutics Ltd has released a press release. View Attachment
View stock analysis, news, and events for Chimeric Therapeutics Limited